Chapter 89 Insurance Company (Please Subscribe)

Wu Siyuan has been in the world of [Fairy in Painting] for hundreds of years, and has almost forgotten the situation in the real world.

Not long after he returned, something happened that shocked the whole world, the Shennongjia Incident. People all over the world were talking about it, which made Wu Siyuan forget that before he traveled through time, the Chaoqun Group was criticized by people all over the world. situation.

Why?

Because this guy priced [redizumab], which can cure late-stage cancer, at $1 million.

That's 1 million US dollars, equivalent to more than 6 million yuan.

How many cancer patients around the world can afford this money?

Cancer is not the same as an orphan disease.

Orphan diseases are actually rare diseases, that is, diseases with an incidence rate of less than 1/10,000 newborns, a prevalence rate of less than 1/10,000 people, and less than 140,000 affected people are classified as rare diseases.

There are more than 7,000 known rare diseases in the world, and there are more than 20 million rare disease patients in China, with more than 200,000 new patients every year.

The number of more than 20 million seems to be a lot, but when spread over various rare diseases, it is not much.

There are more than 20 million rare disease patients, divided by more than 7,000 rare diseases. The number of patients with each rare disease does not even reach 10,000.

Of course, this is not the case in reality.

Since the incidence of rare diseases is very low, the research resources available to them are very limited. Based on economic interests, some pharmaceutical companies are also lack of interest in the research and development, manufacturing or introduction of drugs and food for rare diseases. In addition, many diseases have There are not many cases, making it very difficult to study these diseases. Even if symptomatic drugs are developed, because the patient market is relatively small, their prices are astonishingly high, and they are definitely not affordable by patients.

Drugs to treat orphan diseases are priced high. Although many patients with orphan diseases cannot afford it, at least the public understands that pharmaceutical companies have to recoup the cost of developing drugs. If the pharmaceutical company cannot make money, then the pharmaceutical company will go bankrupt. Without companies developing new drugs, without new drugs, humans will remain helpless against various diseases.

But cancer is not an orphan disease!

Nearly 20 million cancer patients are diagnosed every year, and the number of deaths reaches 10 million.

[Chaoqun Group] sets such a high price to force these patients to die!

Mainly to let patients from abroad die.

At present, [Chaoqun Group] is still in the free trial stage for domestic patients.

In the past, when there was no such drug to treat cancer, everyone could still accept it and die together. It was just a matter of resignation!

But it's different now.

People in China, or rich people, don’t have to die if they get cancer.

And those who have no money will have to die miserably.

Who can accept this?

Now every day, patients from all over the world are requesting [Chaoqun Group] to reduce the cost of [ledimumab] and give cancer patients around the world a way out.

Some send emails.

Well, [Chaoqun Group]’s corporate mailbox is about to explode.

Some are posting videos.

Post videos on all major social media.

There are videos like this of a poor teenage girl who is dying of late-stage cancer, but cannot afford to spend $1 million to buy [ledimumab], and can only wait for death alone in the hospital bed.

Some national politicians directly came forward and asked [Chaoqun Group] to save these poor patients for the sake of humanitarianism.

……………………………………………………………………………………………………………………………… ………

Although the [Shennonjia Forest] incident has attracted much attention in the past, the popularity of [ledimumab] is not low either!

After all, human life matters.

Moreover, as the popularity of the "Shennongjia Incident" slowly receded, the popularity of the "$1 million life-threatening drug" gradually increased.

Wu Siyuan called the group president Huang Yuping and asked Wu Siyuan about Huang Yuping's purchase of insurance companies or insurance licenses before traveling through time.

There are currently more than 160 insurance companies across the country.

Of course, the most famous ones are the dozen or twenty companies, which can be called big insurance companies.

The rest are small and medium-sized insurance companies.

There are some small and medium-sized insurance companies, and many people have never heard of their names in their lives.

According to the [28th Regulation], these small and medium-sized insurance companies are not living very well.

Because my country's insurance market is still at an immature stage, and as a pillar of finance, the development of insurance is closely related to regional policies and financial market development. This has led to a situation where my country's insurance The development of the industry is uneven, and the insurance density and depth of insurance vary greatly between inland and coastal areas, and between western and eastern regions.

To put it bluntly, economic development is not up to standard.

Large insurance companies may not have a big impact, but for small and medium-sized insurance companies, due to the limited industrial scale, lack of high-end talents, high operating costs, and the impact of regional economic development, the number of insurance companies will gradually decrease from coastal areas to inland areas. , gradually decreasing from east to west.

The scale of small and medium-sized insurance companies is also very average.

At the end of the first quarter of 2020, the total assets of insurance companies across the country were 7 trillion yuan, an increase of 6% from the beginning of the year.

Among them, the total assets of property and casualty insurance companies are 4 trillion yuan; the total assets of personal insurance companies are 9 trillion yuan; the total assets of reinsurance companies are 471.4 billion yuan; and the total assets of insurance asset management companies are 65.6 billion yuan.

However, among small and medium-sized insurance companies, which account for more than 87% of insurance companies nationwide, the original premium income and underwriting profits of small and medium-sized life insurance companies only account for 5% and 7% respectively of the industry scale. The proportions of original premium income and underwriting profit of small and medium-sized property insurance companies were 4% and -5% respectively;

At present, the proportion of small and medium-sized insurance companies in my country is still very small.

There is a lot of room for development in terms of high emotional intelligence.

Low emotional intelligence means that you can't do anything anymore.

Many industries rely on scale to make profits.

The larger the scale, the higher the profit, such as fast moving consumer goods.

In the FMCG beverage industry, manufacturers may make less than 2 yuan in profit from a box of beverages, but they can earn huge profits by relying on large-scale sales.

The same is true for the insurance industry.

However, the scale of small and medium-sized insurance companies is inherently low. Naturally, their profits are not much higher.

Data show that the combined profits of the top three property and casualty insurance companies by market share account for approximately 80% of the industry’s total profits.

The remaining 20% ​​of profits are divided among more than 150 insurance companies.

Among them, those relatively large insurance companies took away most of the profits.

For the remaining small and medium-sized insurance companies, let alone profits, it would be great if they could not make losses.

Judging from the data, the average combined ratio of insurance companies with strong capital is 97%, which is profitable; the average combined ratio of medium-sized insurance companies is 102%, struggling at the break-even point; and the combined ratio of small insurance companies is as high as 109% , the performance is worrying.

The argument for high emotional intelligence is poor performance.

The argument for low emotional intelligence is that you are losing money.